Mindtension

Company Overview

Snapshot

Founded in July 2020 by Zev Brand, Sason Noama, and Avi (Avraham) Avital, Mindtension operates with 1–10 employees. The company has raised $5 million across three funding rounds from four investors. In February 2023, Mindtension secured a seed funding round from Arazim.

Business overview

Mindtension develops an affordable, ultra-precise, rapid diagnostic platform designed to measure signs of ADHD. The company's core technology utilizes an electromyography (EMG) system to assess reflexive responses to auditory stimuli and inhibition levels, providing an objective measure of ADHD severity. This in-office diagnostic procedure enables therapists to quickly evaluate the efficacy of ADHD medication and adjust dosages to achieve optimal outcomes. Mindtension operates within the Health Tech & Life Sciences sector, specifically focusing on medical devices and diagnostics for mental health, serving healthcare providers and patients.

Strategic signal

In November 2023, Mindtension, a southern Israeli startup, demonstrated resilience and determination to continue its operations despite regional challenges. This highlights the company's commitment to its mission and operational stability, signaling to investors a robust and dedicated team capable of navigating adverse circumstances while advancing its diagnostic platform.

Company Intelligence Q&A

What is Mindtension's primary focus?

Mindtension focuses on providing an affordable, ultra-precise, rapid diagnostic platform for measuring signs of ADHD, utilizing an electromyography (EMG) system.

When was Mindtension founded and by whom?

Mindtension was founded in July 2020 by co-founders Zev Brand, Sason Noama, and Avi (Avraham) Avital.

How much capital has Mindtension raised to date?

Mindtension has raised a total of $5 million across three funding rounds.

What is Mindtension's core technology?

Mindtension's core technology utilizes an electromyography (EMG) system to measure reflexive responses to auditory stimuli and inhibition levels, providing an objective measure of ADHD severity.

What was a significant operational update for Mindtension in late 2023?

In November 2023, Mindtension, a startup based in southern Israel, affirmed its commitment to continue working despite facing regional challenges, as reported by ISRAEL21c.